A detailed history of Nisa Investment Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,585 shares of ACAD stock, worth $25,946. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,585
Previous 1,328 19.35%
Holding current value
$25,946
Previous $21,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$15.14 - $19.14 $3,890 - $4,918
257 Added 19.35%
1,585 $24,000
Q2 2024

Jul 19, 2024

SELL
$14.62 - $18.42 $9,678 - $12,194
-662 Reduced 33.27%
1,328 $21,000
Q1 2024

May 01, 2024

BUY
$17.79 - $30.86 $1,245 - $2,160
70 Added 3.65%
1,990 $36,000
Q4 2023

Jan 25, 2024

SELL
$20.78 - $31.77 $24,936 - $38,124
-1,200 Reduced 38.46%
1,920 $60,000
Q1 2023

May 02, 2023

BUY
$16.32 - $20.92 $31,987 - $41,003
1,960 Added 168.97%
3,120 $59,000
Q4 2022

Feb 02, 2023

BUY
$14.2 - $18.63 $340 - $447
24 Added 2.11%
1,160 $18,000
Q3 2022

Nov 07, 2022

SELL
$14.11 - $18.27 $4,670 - $6,047
-331 Reduced 22.56%
1,136 $18,000
Q2 2022

Aug 03, 2022

SELL
$13.01 - $27.22 $62,448 - $130,656
-4,800 Reduced 76.59%
1,467 $21,000
Q1 2022

Apr 29, 2022

BUY
$20.94 - $27.5 $131,230 - $172,342
6,267 New
6,267 $152,000
Q4 2021

Feb 03, 2022

SELL
$16.79 - $27.09 $229,149 - $369,724
-13,648 Closed
0 $0
Q3 2021

Oct 18, 2021

SELL
$15.78 - $24.77 $15,038 - $23,605
-953 Reduced 6.53%
13,648 $227,000
Q2 2021

Aug 06, 2021

BUY
$19.4 - $27.42 $68,094 - $96,244
3,510 Added 31.65%
14,601 $356,000
Q4 2020

Jan 25, 2021

BUY
$41.04 - $56.79 $283,955 - $392,930
6,919 Added 165.84%
11,091 $593,000
Q3 2020

Oct 20, 2020

SELL
$36.42 - $57.0 $76,336 - $119,472
-2,096 Reduced 33.44%
4,172 $172,000
Q2 2020

Jul 27, 2020

BUY
$39.26 - $52.73 $3,376 - $4,534
86 Added 1.39%
6,268 $304,000
Q1 2020

Apr 17, 2020

BUY
$31.65 - $46.87 $3,481 - $5,155
110 Added 1.81%
6,182 $261,000
Q4 2019

Jan 17, 2020

BUY
$36.21 - $51.4 $123,186 - $174,862
3,402 Added 127.42%
6,072 $260,000
Q3 2019

Oct 17, 2019

BUY
$22.22 - $44.01 $3,777 - $7,481
170 Added 6.8%
2,670 $96,000
Q3 2018

Oct 16, 2018

SELL
$13.03 - $21.81 $19,545 - $32,714
-1,500 Reduced 37.5%
2,500 $52,000
Q2 2018

Jul 19, 2018

BUY
$15.07 - $22.34 $39,182 - $58,084
2,600 Added 185.71%
4,000 $61,000
Q4 2017

Jan 12, 2018

SELL
$26.84 - $39.14 $13,688 - $19,961
-510 Reduced 26.7%
1,400 $42,000
Q3 2017

Oct 13, 2017

BUY
$29.49 - $38.37 $56,325 - $73,286
1,910
1,910 $72,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.